A Clinical trial of â??NAGA CHENDOORAMâ?? (herbomineral formulation) in management of Karapatha soolai (Diabetic peripheral Neuropathy)

A Clinical trial of â??NAGA CHENDOORAMâ?? in management of Karapatha soolai (Diabetic peripheral Neuropathy)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/01/005347

Enrollment

Registered

2015-01-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diabetic peripheral Neuropathy

Interventions

Intervention1: naga chendooram: 200mg of naga chendooram along with honey bd for 60 days Intervention2: naga chendooram: 200mg bd with honey for 50 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WHO HAVE DIAGNOSED AS NIDDM with peripheral neuropathy symptoms

Exclusion criteria

Exclusion criteria: IDDM PREGNANCY AND LACTATION NEUROPATHY CAUSED BY ANYTHING OTHER THAN DIABETES

Design outcomes

Primary

Measure	Time frame
therapeutic efficacy of the trial drug in the patientsTimepoint: 50 days	—

Secondary

Measure	Time frame
establishment of safety and accuracy of the trial drugTimepoint: 50 days	—

Countries

India

Contacts

Public ContactDrRRamya

NATIONAL INSTITUTE OF SIDDHA

nisdrloga@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026